Search Results for "Changzhou Pharma"
Original Source: Changzhou Siyao Pharmaceuticals CO.,LTD
Changzhou Siyao Pharmaceutical Co.,Ltd. is a comprehensive pharmaceutical company providing full-service of research and development, manufacture, sales and distribution. With over 400 staffs, in 2005, the company's sales amount is 0.5 billion RMB, and the tax paid to the government is 50 million RMB. Changzhou Siyao is a national-grade high-tech enterprise with a post doctorate state. Presently, the Company has obtained GMP-certificate as well as ISO-14001. 3 Products have passed FDA inspection and got CEP...
Matching Channels
The Datamonitor Group aims to help its clients operating in the pharmaceuticals, healthcare and biotechnology fields, offering world-leading products and services to meet the challenges of this rapi...
Labs are the hub of much of modern medicine, either in the hospital setting processing patients blood tests and other samples, in research institutions at many universities or in the headquarters of...
OxyContin, an narcotic analgesic produced by Purdue Pharma LP, nets $3m in sales annually, placing it 8th in the world for annual sales. OxyContin in the brand name for oxycodone, and is similar t...
Lyxumia® is a glucagon-like peptide-1 receptor agonist (GLP-1 RA) for the treatment of patients with type 2 diabetes mellitus. GLP-1 is a naturally-occurring peptide hormone that is re...
Devices - medical, biotech, pharma
A medical device is a product which is used for medical purposes in patients, in diagnosis, therapy or surgery. Medical devices act by physical, mechanical, thermal, physico-chemical or chemic...
Matching News
CORAL SPRINGS, Fla. , March 4, 2013 /- DMH International (OTCBB: DMHI), announced today that their wholly-owned subsidiary, Touch Medical Solutions, Inc (TMSI) has reached an exclusive agreement with...
CORAL SPRINGS, Fla., March 4, 2013 /PRNewswire/ -- DMH International (OTCBB: DMHI), announced today that their wholly-owned subsidiary, Touch Medical Solutions, Inc (TMSI) has reached an exc...
Pharma 3.0 Pulls Companies into the Digital Future
Social media and mobile marketing have kick-started the pharma industry into a phase dubbed Pharma 3.0. Gone are the days of Pharma 1.0 in which companies could rely on a handful of blockbuster drug...
Big pharma companies BMS and Merck are pharma partnering on Daclatasvir
Big pharma company, Bristol-Myers Squibb, is pharma partnering with another big pharma company, Merck, to develop Daclatasvir to treat Hepatitis C. The big pharma companies will work on the hepatitis...
Merck enter pharma partnering pact with Ra Pharma for cyclomimetics
Ra Pharmaceuticals has entered into a pharma partnering deal with Merck, a top 50 big pharma corporation, focused on the development of Cyclomimetics, a new class of compounds that have the diversity...
Verona Pharma plc: Analyst Presentation on the Company Website
LONDON, April 10, 2013 /PRNewswire/ -- Verona Pharma plc ("Verona Pharma" or the "Company") Verona Pharma plc (VRP: London Stock Exchange) ("Verona Pharma", or the "Company"), the biotechnology co...
Big Pharma performance continues to receive muted reviews from various analysts and industry commentators. Pharma Reform starts with an analysis of drug approvals in 2012 by FDA. It is TRUE that 35 dr...
China Biotech In Review: Medtronic Buys China Kanghui For $816 Million
By ChinaBio Today: Deals and Transactions China Kanghui Holdings (NYSE: KH), the Changzhou medical device maker, announced it will be acquired Medtronic (NYSE: MDT) for $816 million or $30.75 per...
Matching PubMed Articles
To observe the short-term effect and adverse reaction of Nimotuzumab in combination with chemotherapy on advanced esophageal squamous cell carcinoma (ESCC).
Entangled nets in coordination compounds with both self-penetrating and interpenetrating structural features have been first constructed by using a flexible bis-pyridinecarboxamide and isophthalate or...
A highly efficient enantioselective Darzens reaction of aldehydes with diazoacetamides catalyzed by a (+)-pinanediol-Ti(O(i)Pr)(4) system has been developed. The cis-glycidic amides were obtained in h...
A facile and efficient method to synthesize 2- or 4-substituted 1,2-dihydroquinolines and quinolines catalyzed by FeCl(3)·6H(2)O (2 mol %) was described. The iron-catalyzed intramolecular allylic ami...
An efficient base-controlled selective conversion of the Michael adducts of malonates with enones in the presence of iodine is reported. Highly functionalized cyclopropane, oxetane, and α-hydroxylmal...
